Who is at high risk of OSA, who should we screen, and why?

J.A. Hedner (Gothenburg, Sweden)

Source: ERS Conference
Number: 23

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J.A. Hedner (Gothenburg, Sweden). Who is at high risk of OSA, who should we screen, and why?. ERS Conference

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Construction of an asthma risk index for high risk children in general practice (ARCADE-study); which characteristics can be useful for this index?
Source: Eur Respir J 2007; 30: Suppl. 51, 380s
Year: 2007

Will the population ²at risk for COPD² develop COPD?
Source: Eur Respir J 2005; 26: Suppl. 49, 218s
Year: 2005

Preselection of patients at high risk for COPD by simple screening questions
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008

Is asthma a risk factor for COVID-19? Are phenotypes important?
Source: ERJ Open Res, 7 (1) 00216-2020; 10.1183/23120541.00216-2020
Year: 2021



Can we correct the cardiovascular risks with treatment?
Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy
Year: 2005

Increasing proportion of children with asthma and atopic disease from high risk families. A consequence of parental recruitment?
Source: Eur Respir J 2006; 28: Suppl. 50, 837s
Year: 2006

’Can do, do do’ concept and all-cause mortality risk in patients with COPD
Source: Virtual Congress 2021 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2021



The effect of OSAS on sick leave and work disability
Source: Eur Respir J 2008; 32: 1497-1503
Year: 2008



Pilot: identification of rehospitalization risk factors for patients with COPD
Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Year: 2005


Adult-onset asthma: is it really different?
Source: Eur Respir Rev 2013; 22: 44-52
Year: 2013



Diastolic dysfunction in patients with overlap syndrome – An early sign of a high cardiovascular risk?
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013


TB vaccination: why, when, how and what?
Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults
Year: 2014




Are patients who overuse short acting β2-agonists more likely to report high levels of asthma symptoms?
Source: Eur Respir J 2003; 22: Suppl. 45, 410s
Year: 2003

The acute PE patient at high risk: how should we manage this patient?
Source: International Congress 2017 – From acute clots to chronic thromboembolic pulmonary hypertension
Year: 2017


Management of high risk patients with COPD, identified by the DOSE index, in general practice
Source: Annual Congress 2009 - COPD case-finding and management in primary care
Year: 2009



COPD screening and risk factor frequency identification study
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013


Clustering in asthma: why, how and for how long?
Source: Eur Respir J 2013; 41: 1247-1248
Year: 2013


What is ‘mild asthma’, and how common is it?
Source: International Congress 2018 – The complexities of managing mild asthma
Year: 2018


Identifying the at risk smokers: who goes on to get COPD?
Source: Eur Respir J, 54 (4) 1901613; 10.1183/13993003.01613-2019
Year: 2019



Obesity, sleep apnoea and COVID-19: relationship, risk and therapeutic implications
Source: Sleep and Breathing Conference 2021
Year: 2021